• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,326.27 403.63
( 0.52%)
Global Indices
Nasdaq
52,333.78 -6.42
(-0.01%)
Dow Jones
7,505.37 -14.99
(-0.20%)
Hang Seng
70,577.01 514.69
(0.73%)
Nikkei 225
10,484.10 -13.02
(-0.12%)
Forex
USD-INR
94.60 0.11
(0.12%)
EUR-INR
107.91 0.13
(0.12%)
GBP-INR
125.27 0.26
(0.21%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Astal Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
512600
INE307N01014
76.1385762
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
47.59
385.61
EPS(TTM)
Face Value()
Div & Yield %
1.85
10
0
 

sheetal diamonds ltd
Groarc Industries India standalone net profit rises 381.82% in the March 2026 quarter
May 30,2026
Net profit of Groarc Industries India rose 381.82% to Rs 0.53 crore in the quarter ended March 2026 as against Rs 0.11 crore during the previous quarter ended March 2025. Sales rose 372.73% to Rs 1.56 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025.

For the full year,net profit declined 60.92% to Rs 0.34 crore in the year ended March 2026 as against Rs 0.87 crore during the previous year ended March 2025. Sales declined 26.16% to Rs 25.69 crore in the year ended March 2026 as against Rs 34.79 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.560.33 373 25.6934.79 -26
OPM %-18.59-163.64 --2.531.72 -
PBDT0.660.04 1550 0.511.21 -58
PBT0.650.04 1525 0.461.17 -61
NP0.530.11 382 0.340.87 -61